Sale!

CYP17A1 Gene 17-Hydroxylation Activity Deficiency Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The CYP17A1 gene plays a crucial role in the production of steroid hormones in the body, including cortisol, androgens, and estrogens. A deficiency in the 17-hydroxylation activity, governed by the CYP17A1 gene, can lead to a rare genetic condition that affects steroid hormone biosynthesis. This condition can manifest in various ways, including adrenal insufficiency and disorders of sex development, depending on the specific mutations in the CYP17A1 gene and the extent of enzyme activity impairment.

To diagnose this condition, a genetic test can be conducted to identify mutations in the CYP17A1 gene that are responsible for the deficiency in 17-hydroxylation activity. DNA Labs UAE offers this specialized genetic test, providing a crucial tool for the diagnosis and management of conditions arising from CYP17A1 gene mutations. The test is priced at 4400 AED and involves collecting a DNA sample from the patient, which is then analyzed for specific genetic mutations associated with the enzyme deficiency.

By accurately diagnosing the genetic basis of the condition, healthcare providers can tailor treatment and management plans to address the specific needs of the patient, potentially improving outcomes and quality of life for those affected by this rare genetic disorder.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CYP17A1 Gene 17-hydroxylation activity deficiency Genetic Test

Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test type: Metabolic Disorders
  • Doctor: General Physician
  • Test Department: Genetics
  • Pre Test Information: Clinical History of Patient who is going for CYP17A1 Gene 17-hydroxylation activity deficiency NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with 17-hydroxylation activity deficiency.

Test Details

CYP17A1 gene 17-hydroxylation activity deficiency is a rare genetic disorder that affects the production of certain hormones in the body, including cortisol and sex hormones. This deficiency can lead to a variety of symptoms and health issues, such as abnormal sexual development, infertility, and adrenal insufficiency.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze an individual’s DNA. It can identify specific genetic mutations or variations in the CYP17A1 gene that may be responsible for the 17-hydroxylation activity deficiency.

The NGS genetic test for CYP17A1 gene 17-hydroxylation activity deficiency involves collecting a sample of the individual’s DNA, usually through a blood or saliva sample. The DNA is then sequenced using NGS technology to identify any mutations or variations in the CYP17A1 gene.

This genetic test can provide important information about an individual’s risk for developing CYP17A1 gene 17-hydroxylation activity deficiency, as well as help with diagnosis and treatment planning. It can also be used for carrier testing in individuals with a family history of the disorder.

It is important to note that genetic testing for CYP17A1 gene 17-hydroxylation activity deficiency should be performed and interpreted by a qualified healthcare professional or genetic counselor, as the results can have significant implications for an individual’s health and well-being.

Test Name CYP17A1 Gene 17-hydroxylation activity deficiency Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Metabolic Disorders
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for CYP17A1 Gene 17-hydroxylation activity deficiency NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with 17-hydroxylation activity deficiency
Test Details

CYP17A1 gene 17-hydroxylation activity deficiency is a rare genetic disorder that affects the production of certain hormones in the body, including cortisol and sex hormones. This deficiency can lead to a variety of symptoms and health issues, such as abnormal sexual development, infertility, and adrenal insufficiency.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze an individual’s DNA. It can identify specific genetic mutations or variations in the CYP17A1 gene that may be responsible for the 17-hydroxylation activity deficiency.

The NGS genetic test for CYP17A1 gene 17-hydroxylation activity deficiency involves collecting a sample of the individual’s DNA, usually through a blood or saliva sample. The DNA is then sequenced using NGS technology to identify any mutations or variations in the CYP17A1 gene.

This genetic test can provide important information about an individual’s risk for developing CYP17A1 gene 17-hydroxylation activity deficiency, as well as help with diagnosis and treatment planning. It can also be used for carrier testing in individuals with a family history of the disorder.

It is important to note that genetic testing for CYP17A1 gene 17-hydroxylation activity deficiency should be performed and interpreted by a qualified healthcare professional or genetic counselor, as the results can have significant implications for an individual’s health and well-being.